Skip to main content
. 2015 Jan 7;4(3):e990773. doi: 10.4161/2162402X.2014.990773

Figure 1.

Figure 1.

Phenotypic and functional assessment of the peripheral NK cell compartment in DLBCL patients at diagnosis. Peripheral blood mononuclear cells PBMCs of newly diagnosed diffuse large B cell lymphoma (DLBCL) patients (gray boxes) and healthy age- and sex-matched controls (empty boxes) were analyzed for: (A) total lymphocyte counts, (B) natural killer (NK) cell subset absolute counts, and (C) NK cell subsets as a percentage of lymphocytes. (D) The percentage of Granzyme B-positive (GrzB+) cells was calculated within each NK cell subset. (E) “Natural” (anti-K562) and CD16-dependent (anti-P815 + anti-CD16 monoclonal antibody [mAb]) cytotoxic activities are expressed in lytic units at 10% cytotoxicity/106 PBMC. (F) The percentage of interferon γ (IFNγ)-producing cells was calculated on gated CD3-CD56+ NK cells. Bars represent median gated CD3-CD56+ NK cells. Bars represent median and 10–90 percentile; dots represent outliers. *P <0.05, **P ≤ 0.01, ***P < 0.0005, ****P = 0.000001.